National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

peplomycin
A semisynthetic analog of Bleomycin, a mixture of several basic glycopeptide antineoplastic antibiotics isolated from the fungus Streptomyces verticillus. Peplomycin forms complexes with iron that reduce molecular oxygen to superoxide and hydroxyl radicals that cause single- and double-stranded breaks in DNA. This agent appears to show greater antitumor activity than bleomycin; its use is limited due to pulmonary toxicity. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:pepleomycin
Abbreviation:PEP
Chemical structure names:
  • (S)-n1-[3-[(1-phenylethyl)amino]propyl]bleomycinamide
  • n1-[3[[(S)-alpha-methylbenzyl]amino]propyl]bleomycinamide



Previous:pentostatin, pentoxifylline, PEP-3-KLH conjugate vaccine, Pepcid, Pepcid AC
Next:Pepto-Bismol, Perdolat, perflubron, perflutren lipid microspheres, perflutren protein-type A microspheres

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov